Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?

BMC Cancer

Table 1 Demographic and available clinical information

Case number	TTP (months)	OS (months)	ETBR expression	Age (years)	Gender	Extent of resection
Case number	TTP (months)	OS (months)	ETBR expression	Age (years)	Gender	Radical	Partial
K7686-2004	4	5	3+	73	M	No	Yes
K9802-2004	5	5	1+	68	M	Yes	No
K4448-2004	1	14	1+	66	M	No	Yes
K12700-2004	1	5	1+	64	F	Yes	No
K10452-2004	7	10	1+	59	F	Yes	No
K5126-2004	3	7	1+	57	M	Yes	No
K11136-2004	12	20	1+	56	M	Yes	No
K17437-2004	16	17	2+	56	M	Yes	No
K4840-2004	7	20	1+	55	M	Yes	No
K16204-2004	10	11	1+	54	M	Yes	No
K9236-2004	12	15	1+	49	F	Yes	No
K16178-2004	12	13	1+	45	M	Yes	No
K3839-2004	12	14	3+	28	M	Yes	No
K16102-2004	48	48	1+	57	F	Yes	No
K17407-2004	48	48	1+	26	F	Yes	No
K10315-2004	52	52	1+	29	M	Yes	No
K3174-2004	15	19	3+	79	F	Yes	No
K16595/04	17	36	1+	53	F	Yes	No
K1716-2005	7	82	1+	43	M	Yes	No
K3349-2005	3	3	3+	79	F	No	Yes
K8622-2005	9	12	3+	59	F	Yes	No
K9731-2005	4	7	3+	52	F	Yes	No
K15725-2005	2	4	2+	54	M	Yes	No
K16886-2005	4.5	14.5	2+	38	F	No	Yes
K17972-2005	8.5	18	1+	63	F	Yes	No

TTP time to tumor progression, OS overall survival; Staining was graded as low (1+) or high (2+ and 3+)

ISSN: 1471-2407